Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Boehringer Ingelheim | Contract Pharma

What are you searching for?

Sign in
Breaking News, Promotions & Moves

Boehringer Ingelheim

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Albert Ros has been appointed executive vice president of sales and marketing for Boehringer Ingelheim’s prescription medicines business. In his new role, Mr. Ros will lead the U.S. sales and marketing strategy of the company’s core brands.

“We are pleased to have Albert in such an important leadership role,” said J. Martin Carroll, president and chief executive officer, Boehringer Ingelheim. “Albert is a valuable member of the Boehringer Ingelheim team and he possesses an impressive range of global sales and marketing experience.”

Mr. Ros has been with the company for 14 years and previously served as head of the corporate division for marketing of prescription medicines. In this position, Mr. Ros led the development of four global products including Spiriva, Flomax, Mirapex and Micardis. Previously, he served as the country manager for Boehringer Ingelheim Brazil and the business unit head of Boehringer Ingelheim Spain.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters